Keyphrases
Breast Cancer
100%
Functional Significance
100%
Receptor Expression
100%
Erythropoietin Receptor
100%
EpoR
100%
Erythropoietin
81%
Tumor
36%
Breast Cancer Cells
27%
Tumor Cells
18%
Cancer Cells
18%
Colocalization
18%
Tumor Hypoxia
18%
Erythropoiesis
18%
Erythropoietin Expression
18%
Pimonidazole
18%
Protein Expression
9%
In Cancer
9%
Tumor Growth
9%
Hypoxia
9%
Syngeneic
9%
In Vivo Function
9%
Nonhematopoietic
9%
Biologic Effect
9%
Janus Kinase 2 (JAK2)
9%
Immunohistochemical Analysis
9%
Patients with Breast Cancer
9%
Dose Effect
9%
Mitogenesis
9%
Expression Pattern
9%
Tyrosine Kinase
9%
Human Breast Cancer Cells
9%
Fibrin Gel
9%
Breast Cancer Cell Lines
9%
Membrane Receptors
9%
Plexiglas
9%
Subcutaneous Tissue
9%
Tumor Biopsy
9%
Hematopoietic Cytokines
9%
Hypoxia Markers
9%
Functional Receptor
9%
Tissue Culture Cells
9%
Mammary Adenocarcinoma Cells
9%
Antitumor Compounds
9%
Soluble Erythropoietin Receptor
9%
Tumor Depth
9%
Chamber Model
9%
Anti-erythropoietin Antibodies
9%
Breast Cancer Tissues
9%
Medicine and Dentistry
Breast Cancer
100%
Receptor Expression
100%
Erythropoietin Receptor
100%
Erythropoietin
100%
Cancer Cell
54%
Neoplasm
54%
Hypoxia
18%
Receptor
18%
Tumor Cell
18%
Tumor Hypoxia
18%
Pimonidazole
18%
Erythropoiesis
18%
Protein Expression
9%
Tumor Progression
9%
Cytokine
9%
Protein Tyrosine Kinase
9%
Mitogenesis
9%
Breast Adenocarcinoma
9%
Biopsy Technique
9%
Tissue Culture Cell
9%
Subcutaneous Tissue
9%
Cancer Tissue
9%
Breast Cancer Cell Line
9%
Tumor Biopsy
9%
Poly(methyl Methacrylate)
9%
Erythropoietin Antibody
9%
Messenger RNA
9%
Biological Activity
9%
Biochemistry, Genetics and Molecular Biology
Erythropoietin Receptor
100%
Erythropoietin
100%
Cancer Cell
58%
Erythropoiesis
16%
Tumor Hypoxia
16%
Tyrosine Kinase
8%
Syngenic
8%
Protein Expression
8%
Mitogenesis
8%
Transmembrane Receptors
8%
Tissue Culture Cell
8%
Cytokine
8%
Receptor Tyrosine Kinase
8%
Tumor Progression
8%
Messenger RNA
8%
Porosity
8%
Biological Activity
8%